ALEXANDRIA, Va., July 16 -- United States Patent no. 12,357,636, issued on July 15, was assigned to Urovant Sciences GmbH (Basel, Switzerland).
"Vibegron for the treatment of overactive bladder symptoms" was invented by Paul N. Mudd Jr. (Cary, N.C.), Cornelia Haag-Molkenteller (Irvine, Calif.) and Jihao Zhou (Rancho Santa Margarita, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to a method of treating overactive bladder symptoms in men with benign prostatic hyperplasia comprising orally administering to a subject in need thereof an amount of from about 60 mg to about 90 mg (e.g., about 75 mg) of vibegron per day."
The patent was filed on Dec. 5, 2019, under Applica...